COVID-19 Respiratory Infection
📧 Sign up to get email alerts when something new happens for COVID-19 Respiratory Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
ClinicalTrials.gov entry indicates the Passive Detection SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) study for operational medici…
-
CLINICAL_TRIALS withdrawal · 2024-01-12Clinical Trial Update: PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT) [Phase 2, Phase 3]
A COVID-19 related preventive study (PREVENT) in Phase 2/3 was withdrawn from clinical trials.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the immunogenicity, efficacy, and safety of the Convacell vaccine in healthy adults aged 18 and older …
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: NAC for Attenuation of COVID-19 Symptomatology [Phase 2]
A Phase 2 clinical trial is updating on N-acetylcysteine (NAC) for attenuation of COVID-19 symptomatology, with various COVID-19-related res…
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Role of Vit-D Supplementation on BioNTech, Pfizer Vaccine Side Effect and Immunoglobulin G Response [Phase 3]
Phase 3 trial investigating whether vitamin D supplementation affects vaccine side effects and IgG response to the BioNTech/Pfizer COVID-19 …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is investigating ramatroban in addition to standard of care for hospitalized COVID-19 pneumonia patients; t…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients [Phase 2, Phase 3]
A completed phase 2/3 trial investigating the effectiveness and safety of an isothymol or carvacrol compound for COVID-19 patients.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19 [Phase 3]
Phase 3 clinical trial update for PROlectin M, an antagonist targeting nucleocapsid terminal region, in COVID-19; current status unknown.
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Safety and Effectiveness of an Immunobiological Drug in CoViD-19 [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update reports on the safety and effectiveness of an immunobiological drug for COVID-19 pneumonia and respi…
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation [Phase 4]
Phase 4 clinical trial examining COVID-19 morbidity in healthcare workers and the effect of vitamin D supplementation; study completed.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients [Phase 1, Phase 2]
Clinical trial update describes CRISPR/Cas9-modified T cells targeting PD-1 and ACE2 for inducing long-term immunity in COVID-19 patients, w…